Abstract
Context: Erythrocytosis is a known side effect of testosterone therapy that can increase the risk of thromboembolic events.
Objectives: To study the prevalence and determinants in the development of erythrocytosis in trans men using testosterone.
Design: A twenty-year follow-up...